Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialPubMedOpen access

Intraarticular injection of the stromal vascular fraction for the treatment of knee osteoarthritis a prospective randomized controlled clinical trial.

Lu J., Wen T., Huang H., Xie C., Kang J., Huang J.

Randomized Controlled Trial with a reported sample of 62 on Knee Osteoarthritis, Osteoarthritis, published in Sci Rep (2025) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
Sci Rep (2025)
Country
England
Reported sample size
62
Source database
PubMed
PMID
40750958
PMCID
PMC12317020
DOI
10.1038/s41598-025-09398-w
Citations
1

Abstract (original English)

Currently, conservative treatment for knee osteoarthritis (KOA) has limited efficacy, and autologous adipose-derived stromal vascular fraction (SVF) knee injections, a novel treatment approach, are receiving widespread attention. Our study aimed to explore the efficacy and safety of SVF treatment for KOA patients. This randomized controlled trial sought to assess the efficacy and safety of intra-articular SVF injections for the treatment of KOA, both as an independent intervention and in conjunction with conventional rehabilitation. Sixty-six KOA subjects were randomly divided into three groups: (1) the SVF group received a single SVF intra-articular knee injection; (2) the control group received conventional rehabilitation treatment (muscle strength training, interferential therapy, and manual therapy, 5 times a week for a total of 4 weeks); and (3) the combination therapy group received a single SVF intra-articular knee injection followed by conventional rehabilitation treatment. Outcomes were assessed during a 12-month follow-up period, with outcome measures including the visual analog scale for pain; the Western Ontario and McMaster Universities Osteoarthritis Index for pain, stiffness, and function; range of motion (ROM); and the occurrence of complications. A total of 62 patients completed the follow-up. There were no significant baseline differences among the groups. The

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
HumansOsteoarthritis, KneeMaleFemaleInjections, Intra-ArticularMiddle AgedAgedTreatment OutcomeProspective StudiesRange of Motion, Articular

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research